Back to 
Royal Bank of Canada
Royal Bank of Canada
MRKR
Showing 1 of 7 quarters
Position history for Royal Bank of Canada's holdings in Marker Therapeutics, Inc.
No. Royal Bank of Canada exited its MRKR (Marker Therapeutics) position in Q3 2024. Its Q2 2024 13F listed 15 shares. Royal Bank of Canada first reported MRKR in Q1 2023 and held it in 6 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History